The Science of CBD
Enveric Biosciences seeks to advance novel combinations of CBD with chemotherapeutic agents and immunotherapies.
Development Programs
Enveric Biosciences has a robust pipeline with multiple data points expected in 2021 for radiodermatitis, glioblastoma and chemotherapy-induced neuropathy.